lef-11, and dnapol genes were screened and identified as multiple sgRNA editing sites according to the BmNPV system infection and DNA replication mechanism.
Introduction
Bombyx mori nucleopolyhedrovirus (BmNPV) is an alphabaculovirus genus in the family baculoviridae [1, 2] . BmNPV have a large circular, supercoiled, double-stranded DNA genome with 128,413 nucleotides containing 141 open reading frames (ORFs) packaged into rod-shaped virions [1, 3] . Sericulture in China, India, Japan and Southeast Asia is the most developed, and BmNPV is the most common and serious disease in silkworm, accounting for about 70%−80% of the total losses caused by silkworm disease [4] . The main measures to prevent and control BmNPV is breeding resistant varieties via genetic breeding and transgenic breeding [5] . However, the overexpression of antiviral genes (such as Bmlispase-1, serine protease-2, Sprouty, BmAtlastin-n and NADH-oxidoreductase-like protein gene) and RNA interference (RNAi) of BmNPV key genes (such as immediate early-1 (IE-1), late expression factor 1 (lef-1), lef-2, lef-3, lef-11, oral infection factor p74, and gp64 gene) by transgenic technologycannot meet the needs of the sericulture industry [4] [5] [6] [7] [8] [9] .
An intriguing new strategy that can eradicate virus replication using the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 nuclease (CRISPR/Cas9) genome editing technology has been widely used in pathogenic viruses including human immunodeficiency virus 1 (HIV-1), human papillomavirus, hepatitis B virus (HBV), Epstein-Barr virus, plant virus, or flaviviruses in infected cells or animal models [10, 11] . In the past 4 years, Cas9 technology has been extensively utilized in basic science and transgenic breeding settings to treat genetic diseases and infectious diseases in silkworm [12] [13] [14] . Our laboratory has employed CRISPR/Cas9 technology and developed a BmNPV specific gene editing system to excise the BmNPV genome ie-1 gene from infected cells of Bombyx mori for the first time [15] .
Since 2017, many of antiviral strains, including gene editing of ie-0, ie-1, ie-2, or me53 genes, have been cultivated through transgenic breeding mainly through strategies of signal gene editing, double gene editing, and large fragment deletion [12, 13] . At the same time, we have established a virus-inducible CRISPR/Cas9 system that can reduce the off-target efficiency and host toxicity of gene editing systems. It not only could edits the key BmNPV gene directly but can also edit the virus-dependent host factors to inhibit the multiplication and replication of BmNPV [16] . All of these antiviral strains have achieved remarkable antiviral effects through transgenic genome editing. However, the introduction of nucleases into cells by these nuclease-based genome editing methods is still inefficient and has partial selectivity of viral gene editing for removing the entire BmNPV genome [13, 14] . Therefore, there is an urgent need to screen and identify BmNPV genes and used them to improve the antiviral viability by multi-gene editing in the BmNPV genome.
To achieve highly specific BmNPV genome editing, this work applied a highly efficient multiplex CRISPR/Cas9 gene editing technology to disrupt the BmNPV genome in infected silkworm cells. We first constructed a one-vector CRISPR/Cas9 gene editing system, pSL1180-Cas9-U6-sgRNA plasmid, using the BmNPV lef-11 gene as a target gene. This can quickly insert target genes and detect antiviral activity.
We also screened and identified ie-1, gp64, lef-11 and dnapol genes, which are very important for viral replication based on the BmNPV systemic infection and DNA replication mechanism. More importantly, to completely eliminate the BmNPV genome from infected silkworm cells, we constructed a multiplex CRISPR/Cas9 system for using an anti-BmNPV therapeutic. The results demonstrated a series of sgRNA for highly active candidates that would be optimal for therapeutic application and successful construction of a multiplex CRISPR/Cas9 genome editing system with the ability to inhibit BmNPV replication.
Materials and Methods

Cells and Viruses
The Bombyx mori (ovarian) cell line BmN-SWU1 were grown in TC-100 medium containing penicillin/streptomycin and 10% fetal bovine serum at 27℃ [17] .
Recombinant BmNPV (v39K prm -EGFP) was constructed as previously [8, 18] .
Recombinant BmNPV were generated on BmN-SWU1 cells [18] .
Plasmid construction
The gene encoding Cas9 nuclease and the expression cassette for sgRNA were prepared as described previously [15] . The resulting Cas9 and sgRNAs expression vectors were named as pSL1180-IE1-Cas9-SV40-U6-sgRNA. Two pairs of sgRNA were designed using the CRISPR website (http://crispr.dbcls.jp/) and targeted to the amino-terminal regions of BmNPV key gene ORFs [19] . All sgRNA scaffold target sequences were inserted the Bbs I restriction enzyme site. All clones were verified by sequencing the plasmids. All primers used here are presented in Table S1 . 
Immunofluorescence
sgRNA design
As previously reported sgRNA against BmNPV generated via the online analysis tool (http://crispr.dbcls.jp/) and the sequence listed as Table S2 [19] . Scanning for GN19NGG sequences on the BmNPV genome identified anti-BmNPV sgRNA candidates that met the rules: as a target sequence and own the PAM recognition domain.
Sequence analysis
Wizard Genomic DNA extraction kit (Promega, USA) was used for BmNPV genome DNA extraction. The BmNPV genomic region surrounding the sgRNA target site of each gene was amplified by PCR, and detected the cleavage of the lef-11 gene.
The PCR products were purified and ligated into the pEASY-T5 vector (TransGen Biotech, Beijing, China) and submitted for sequencing using universal primers (BGI, Guangzhou, China).
Western Blot analysis
The transfected cells were lysed in Western and IP buffer containing 20 mM Tris-HCL, pH7.5，150 mM NaCl, 1% Triton X-100 (Beyotime, China) and mixed with 5×loading buffer and boiled for 5 min. The protein samples were separated through 12% SDS−PAGE and transferred onto the PVDF membrane. After blocking, the membranes were incubated with primary antibodies: rabbit ɑ-VP39 (1:2000), and rabbit ɑ-Tubulin (1:5000; Sigma, USA) in 5% milk in TBST for 1 h at room temperature. After washing, the blot was treated with a HRP−labeled goat anti-rabbit IgG (1:20,000; Beyotime) reacted in Clarity Western ECL Substrate (Bio-Rad, USA); finally, the sample was exposed to X-ray film for detection.
Quantitative PCR (qPCR) for DNA replication assay
The BmNPV genome DNA was subjected to real-time PCR using SYBT Premix Ex Taq (TaKaRa, Dalian, China) following a previously described protocol and using cDNA specific primers previously by Dong et al [20] . For quantification, a DNA standard curve was constructed based on Ct values (Bio-Rad) as previously described for calculation of the copy number of the gp41 gene.
Reverse transcription-PCR (RT-PCR)
RNA extractions were performed using TRIZOL RNA extraction kit from Invitrogen research (Invitrogen, USA). The cDNA synthesis used a reverse transcription Kit (Promega). SYBR Select Master Mix Reagent (Bio-Rad, USA) was using for RT-PCR reactions. The specificity of the primers was confirmed by agarose gel electrophoresis and melting curve analysis. The results are expressed as fold-increase expression of the gene of interest normalized to B. mori sw22934 gene expression using the 2 -∆∆Ct method.
Statistical analysis
All data are presented as mean±SD. An unpaired, one-tailed Student's t tests was used to compute the difference between two independent groups. Differences with P < 0.01 were considered to be statistically significant.
Results
Establishment of a one-vector CRISPR/Cas9 system for BmNPV genome excision
BmNPV contains 141 genes most of which have not been studied [1, 21] . To systematically compare the effects of different gene knockouts on the replication of BmNPV, we constructed a one-vector CRISPR/Cas9 system for rapid detection of inhibition of BmNPV multiplication. We linked Cas9 and U6-sgRNA expression cassettes into a single pSL1180 vector, which contain two Bbs I digestion sites that could link the BmNPV target sequence directly ( Figure 1A) . Previously, we demonstrated that the BmNPV lef-11 gene is necessary for virus replication [22] . Here, we first detected gene editing and antiviral efficiency of the system by knocking out lef-11. After transfecting three different target sites for the lef-11 gene into BmN-SWU1 cells, the BmNPV genome copy was detected with the RT-PCR assay.
These results showed that the amount of BmNPV DNA in the cells treated with sgLEF11-1, sgLEF11-2 and sgLEF11-3 was lower than in cells transfected with sgMock plasmids indicating that the DNA levels in the cells transfected with 
Screening of key genes involved in BmNPV systemic infection
Baculovirus replication is a cascade of regulation and is mainly divided into four periods: immediate early, early, late and very late (Figure 2A) . Therefore, to reduce the screening range, we selected key genes from different periods to detect the effect on BmNPV replication after knockout using CRISPR/Cas9 system. Immediate early Figure 2B ). Statistical analysis showed that sgIE1 had only a 23% infection rate, sgGP64 were 26%, and the controls were 51%, sgVP39 or sgPOLY also had a corresponding decrease after 72 h p.i. (Figure 2C ). The result of qPCR analysis clearly showed that the relative amount of BmNPV DNA was decreased by the cells treated with target genes but not sgMock, revealing more than a 10-fold reduction in DNA levels in the cells transfected with sgIE1 and sgGP64 ( Figure 2D ). These results indicated that the excision of immediate early and very early genes from the BmNPV genome by the CRISPR/Cas9 system could effectively inhibit BmNPV replication. 
Screening of key genes involved in BmNPV DNA replication
The key baculovirus DNA replication genes ie-1, lef-3, p143, lef-1, and dnapol are essentially involved in DNA replication; the function of most DNA replication related genes is unknown in BmNPV ( Figure 3A ) [23] . According to the principle that BmNPV early expression gene has a greater influence on viral DNA replication, we selected ie-1, lef-3, lef-11, ie-2, p35, p143, lef-1, and dnapol genes as the candidate target genes using a one-vector CRISPR/Cas9 system. To evaluate the efficacy of selected sgRNAs in targeting BmNPV, we transfected one-vector CRISPR/Cas9 system into BmN-SWU1 cells. At 72 h p.i., sgIE1, sgLEF-3, sgDNApol and sgLEF-11 could inhibit the expression of EGFP fluorescent protein more effectively than in the cells transfected with sgLEF1, sgP143, sgIE2, sgP35, and sgMock ( Figure   3B ). Statistical analysis showed that the EGFP-positive cells among transfected sgIE1, sgLEF-3, sgDNApol, and sgLEF-11 cells were only 20%−30% compared with 50% for sgMock ( Figure 3C ). Further analysis of BmNPV DNA replication showed that sgIE1, sgDNApol and sgLEF11 were more effective at inhibiting viral DNA replication in all target genes. The number of copies of BmNPV gp41 in cells transfected with sgIE1, sgDNApol and sgLEF11 were 10-fold lower than those transfected with sgMock ( Figure 3D ). 
CRISPR/Cas9-mediated multiplex gene editing impairs BmNPV replication
Next, we wondered if a combination of dual sgRNA or multiple sgRNAs could more effectively inhibit of virus replication. To examine this possibility, we used cells transduced with signal and double sgRNAs disruption of BmNPV infection via a one-vector system. The results show that the double sgRNAs inhibits viral infection more completely than targeted Cas9 ( Figure S1 ). Thus one CRISPR/Cas9 genome editing system might be able to perform multiple sgRNAs and Cas9 gene edits simultaneously [24] . Therefore, we choose ie-1, gp64, lef-11, and dnapol as target genes for multi-gene editing through systematic screening combined with baculovirus infection process. The sgRNA and Cas9 expression cassettes were constructed into a one-vector system ( Figure  4A ). The vector is named PSL1180-Cas9-sgIE1-sgLEF11-sgGP64-sgDNApol (sgMultiple). [33, 34] .
Other approaches will edit transgenic silkworms infected with bacterial diseases, fungal diseases and Nosema bombycis according to the characteristics of different silkworm diseases. Currently, the CRISPR family has identified gene editing systems including CRISPR/CPF1 and CRISPR/Cas13, that could edit the DNA, RNA or both DNA and RNA sequences [35, 36] . CRISPR/CPF1 and CRISPR/Cas13 systems have smaller nuclease proteins and have more RNA target sequences and lower off-target efficiency. These can be systematically applied to research of silkworm disease resistance breeding. The results will advance the sericulture industry [37] . In the future, it will be possible to completely prevent and control silkworm infectious diseases.
In conclusion, the multiplex CRISPR/Cas9 system can use an anti-BmNPV therapeutic with great potential for genome editing. It will be applied to the field of gene therapy [38] [39] [40] [41] [42] [43] . We constructed a multiplex CRISPR/Cas9 system with high efficiency gene editing and antiviral ability. The successful application of this multiplex CRISPR/Cas9 genome editing technology offers new insights to improve strategic inhibition of multiple silkworm pathogens simultaneously. Table S1 . Sequences of primers used in this study. Table S2 . The sgRNA target sequences of primers used in this study.
